News
Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections (ALRTIs) in children under five and poses a persistent threat to child health worldwide.
Cases of human metapneumovirus, or HMPV, a contagious virus that can lead to respiratory disease, is reportedly spiking in northern China. Infectious disease experts say risk to the U.S. is low.
As China continues to monitor an increase in cases of human metapneumovirus ... MORE: Cases of RSV, flu ticking up among young children in US as respiratory virus season begins ...
Hosted on MSN11mon
Moderna rival CSPC cleared to study RSV shot in China - MSNModerna (NASDAQ:MRNA), the only company to market a messenger RNA-based vaccine against the respiratory syncytial virus (RSV), will soon face competition from China as regulators in the country ...
Mild cases of HMPV usually last a few days to a week, and many people recover by themselves within two to five days. “It will present in the same way as flu, sars-cov-2, RSV, so the same advice ...
So when the recent outbreak in northern China was met with widespread alarm, Williams allowed himself a wry smile. The forgotten burden of public health was finally being taken seriously.
In China, RSV accounted for an estimated 3.5 million ALRTI cases and up to 950,000 hospitalizations in 2019—nearly one-quarter of the global burden. While most cases are mild, ...
The human metapneumovirus, also known as HMPV, is reportedly surging in China, raising questions about what the illness is and if it's a concern to those in the U.S.. Officials in India have also ...
Enjoy, and see you soon… A fast-growing group of Americans is turning to what many call the “gray market” for obesity ...
Merck & Co., Inc. (NYSE:MRK) is one of the 10 Best Value Stocks to Buy According to Billionaires. The company announced that ...
China's National Medical Products Administration has given regulatory clearance for CSPC Pharmaceutical Group's respiratory syncytial virus (RSV) vaccine candidate to begin human clinical trials ...
A new national guideline provides evidence-based recommendations for diagnosing, treating, and preventing pediatric ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results